Recent Finacing
Recent Raise
Shasqi is a clinical-stage San Francisco biotech developing CAPAC click-chemistry therapeutics that use injected tetrazine-modified biopolymers to locally activate intravenously delivered protodrugs at tumor sites.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Shasqi.
